Literature DB >> 9856777

SPARC deficiency leads to early-onset cataractogenesis.

K Norose1, J I Clark, N A Syed, A Basu, E Heber-Katz, E H Sage, C C Howe.   

Abstract

PURPOSE: To determine the role of SPARC (secreted protein, acidic, and rich in cysteine) in cataractogenesis by examining mice deficient in a matricellular protein SPARC.
METHODS: Mice were rendered SPARC-deficient by a targeted disruption of the gene. Slit-lamp microscopy and histology were used to examine the eyes of SPARC-null and wild-type mice from birth to 14 months of age.
RESULTS: SPARC-null mice developed opacities in the posterior cortex of the eye as early as 1.5 months after birth. The diffuse cataracts appeared to progress toward the anterior cortex and reached maturity in many animals by 3.5 months of age. Early stages of cataractogenesis in SPARC-null mice included inhibition of normal lens fiber cell differentiation, degeneration of fiber cells, vacuole formation at the equator, and liquefaction of the cortex. No cataracts were detected in wild-type mice up to the age of 8 months.
CONCLUSIONS: The early onset of cataracts in SPARC-null mice establishes that the gene is essential to the maintenance of lens transparency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856777

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  74 in total

1.  Osteonectin/SPARC secreted by RPE and localized to the outer plexiform layer of the monkey retina.

Authors:  I R Rodríguez; E F Moreira; D Bok; M Kantorow
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2.

Authors:  Z Yang; T R Kyriakides; P Bornstein
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

3.  Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization.

Authors:  Hiroe Toba; Lisandra E de Castro Brás; Catalin F Baicu; Michael R Zile; Merry L Lindsey; Amy D Bradshaw
Journal:  Am J Physiol Cell Physiol       Date:  2015-04-15       Impact factor: 4.249

Review 4.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 5.  Effects of bone matrix proteins on fracture and fragility in osteoporosis.

Authors:  Grażyna E Sroga; Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

6.  Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Authors:  Neveen Said; Henry F Frierson; Marta Sanchez-Carbayo; Rolf A Brekken; Dan Theodorescu
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

7.  Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression.

Authors:  Fiona C Mansergh; Timothy Wells; Carole Elford; Samuel L Evans; Mark J Perry; Martin J Evans; Bronwen A J Evans
Journal:  Physiol Genomics       Date:  2007-09-18       Impact factor: 3.107

8.  Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Authors:  Shanna A Arnold; Lee B Rivera; Andrew F Miller; Juliet G Carbon; Sean P Dineen; Yang Xie; Diego H Castrillon; E Helene Sage; Pauli Puolakkainen; Amy D Bradshaw; Rolf A Brekken
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

9.  Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.

Authors:  Shawna L Bull Phelps; Juliet Carbon; Andrew Miller; Emely Castro-Rivera; Shanna Arnold; Rolf A Brekken; Jayanthi S Lea
Journal:  Am J Obstet Gynecol       Date:  2008-11-06       Impact factor: 8.661

10.  Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs.

Authors:  Mark A Pershouse; Aubrey M Smartt; Corbin Schwanke; Elizabeth A Putnam
Journal:  Genomics       Date:  2009-05-13       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.